Transcatheter mitral valve technologies
Transcription
Transcatheter mitral valve technologies
Transcatheter mitral valve technologies by development stage Innovation booklet Source: cvPipeline, April 2016 EuroPCR - 17–20 May 2016 - Paris Programs in the Clinic Company Product Abbott (US) Tendyne TMVI CardiAQ (US) CardiAQ-Edwards Valve-TA and TF Medtronic Neovasc (Canada) Intrepid TMVR Tiara Features – Features a left ventricular apical tether – Leaflet indifferent, allowing it to be placed in a variety of pathologies – Fully retrievable and repositionable – Transapical delivery system – Self-positioning, self-anchoring, and self-conforming – Preserves sub-valvular apparatus – Minimal risk of LVOT obstruction – Transapical and transseptal delivery systems Status CE Mark trial planned, US Feasibility study underway Abbott acquired Tendyne 9/15 CE Mark trial (RELIEF) planned, US Feasibility study underway Edwards acquired CardiAQ 8/15 – Dual stent system – Fixation and sealing is achieved by a “cork”effect First-in-man produced by variable stiffness along the height of the outer study underway stent in Poland – Transapical delivery – D-shaped trileaflet mitral valve to match the natural shape of the mitral orifice – Spares chordal structure – Transapical delivery system Notes CE Mark trial planned, US Feasibility study underway Medtronic acquired Twelve 10/15 35 mm valve used initially; 40mm valve now available for clinical use, 45 mm valve in development Programs in the Clinic Company Product Features Notes Braile Biomedica (Brazil) Inovare Mitral – Self-expandable valve for use in the native mitral valve OUS First-in-man study planned Caisson (US) Caisson TMVR – Modular approach to treating MR - Transfemoral delivery system Founders associated with Myocor; LivaNova has an investment stake Cephea (US) Cephea TMVR – Designed to recreate the annular plane, mimicking the surgical approach Abbott has an investment – “Unique” folding mechanism enables transseptal delivery stake and an option to – Transseptal delivery system acquire Direct Flow Medical DFM TMVR – Double-ring valve for optimal sealing – Valve design accommodates D-shape of the mitral annulus – Metal-free design/profile facilitates transseptal delivery – Transapical delivery system HighLife System – Respects the mitral valve anatomy – Porprietary Loop Placement Catheter (LPC) – Self-centering and self-positioning upon release – Procedure fully reversible to valve deployment – Transapical or transatrial delivery HighLife (France) Preclinicals completed; LivaNova has an investment stake Programs in the Clinic Company Product Features Notes HT Consultant (Switzerland) Saturn TMVR – Annular structure to “embrace” the mitral valve – Valved central element that is expanded inside the mitral orifice to fit the annular structure – Transapical delivery system Inventor is Giovanni Righini Lutter (Germany) Lutter valve – Mitral valved stent – Ventricular fixation system – Transapical delivery system Inventor is Georg Lutter MitralHeal (Israel) MitralHeal – Not sensitive to native mitral valve size or shape – 1 size fits all – Designed to eliminate any paravalvular leak MitrAssist (Israel) MitrAssist Valve – Fits into the existing mitral valve – Delivered through a small-diameter catheter – Treats all forms of mitral regurgitation – Potential for repositioning – Transfemoral delivery system Founded by Israeli innovator Gil Naor Navigate (US) Navigate TMVR – Features a nitinol stent and dehydrated tissue – Annular winglets around lower portion of the valve for secure anchoring – Delivery options include a transseptal approach Technology licensed from Cleveland Clinic Programs in the Clinic Company Product Features SINOMED (China) AccutFit – Reverse leaflet and conventional leaflet versions designed to eliminate central leakage – Includes a sealing ring design (synthetic material) to minimize PVL and a valve holder for optimal valve positioning – Transapical delivery system Transcatheter Technologies (Germany) Tresillo – Pre-mounted valved stent that is folded without the need of an outer sheath – Allows for multiple-shot repositioning and retrieval – Transfemoral delivery system Valtech (Israel) CardioValve – 5 degress of steerability – Ventricular and atrial anchoring mechanism – Transseptal and transapical delivery systems Notes Early Stage Programs Company Product Features Emory University (US) MitraCath – Based on the use of a nesting design between 2 opposing selfexpanding stents – Separates the impact of variability in a patient’s valve/annular geometry from the bioprosthetic valve to be implanted INVALV (France) INVALV Device – OUS patent WO2013072498 Micro Interventional Devices (US) Endovalve – Foldable valve replacement system to treat mitral regurgitation – Features use of Perm seal device to create operative window for procedure – Transapical delivery system Mitralix (Israel) MAESTRO – Company has announced plans to develop a percutaneous mitral valve replacement device Mitraltech (Israel) Mitraltech TMVR – IP describes a collapsible prosthetic valve designed for full or partial replacement of the native mitral valve MITRICARES (France) MITRICARES Device – IP describes an anchoring device for implanting a prosthetic heart valve at a valve annulus of a patient Nakostech (France) Nakostech TMVR – IP describes an expandable mitral valve replacement system with a reliable locking system Notes Inventors are Drs. Sai Muralidhar Padala and Vinod Thourani Original development company acquired by Micro Interventional Devices One of the founders is Israeli innovator Yossi Gross Early Stage Programs Company Product Features ATLAS TMV – Designed to preserve original anatomy – Includes an optional sealing membrane to prevent paravalvular leakage – Transapical delivery system Transcatheter Technologies Tresillo – Pre-mounted valved stent folded witout the need of an outer sheath, enabling precise controlled positioning, repositionable – “Platform” technology that will be utilized for several devices (including TAVI systems) Transmural Systems Transmural TMVR – IP describes a valve prosthesis that includes a series of connected loops that form a structure for placement in the annulus St. George (Bahamas) Notes Transcatheter mitral valve technologies by development stage Innovation booklet Source: cvPipeline, April 2016
Similar documents
Percutaneous Intervention in Mitral Valve Disease
long-term clinical results and carries a low risk when performed by experienced teams. Patient selection must be based on anatomy as
More informationPercutaneous Mitral Valve Repair
• With the exception of use of the MitraClip for degenerative mitral regurgitation in high risk surgical patients, virtually everything else is either investigational or an off-label use of a device.
More information